Cecília da Silva Ferreira

Cecília da Silva Ferreira

Auto-generated profile, based on publicly available information

Cecília da Silva Ferreira

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
GCGiovanna Santos Cavalcanti
Giovanna Santos Cavalcanti
KCKatia Candido Carvalho
Katia Candido Carvalho
CFCecília da Silva Ferreira
Cecília da Silva Ferreira
PCPeter Chedraui
Peter Chedraui
PMPedro Augusto Araújo Monteleone
Pedro Augusto Araújo Monteleone
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
The main consequence of delaying motherhood is compromising a woman's reproductive life with a decline in fertility. A critical step in assisted human reproduction is the evaluation of the quality of oocytes and embryos before embryo transfer, and age is a predominant factor in that capacity. In fact, granulosa cells (GCs) have been proposed as fundamental for the quality of oocytes due to their close biodynamic interrelationship1 1 Broi MG, Giorgi VSI, Wang F, Keefe DL, Albertini D, Navarro PA. Influence of follicular fluid and cumulus cells on oocyte quality: clinical implications. J Assist Reprod Genet. 2018;35(5):735-51. https://doi.org/10.1007/s10815-018-1143-3 https://doi.org/10.1007/s10815-018-1143-... ,2 2 Mintziori G, Mousiolis A, Duntas LH, Goulis DG. Evidence for a manifold role of selenium in infertility. Hormones (Athens). 2020;19(1):55-9. https://doi.org/10.1007/s42000-019-00140-6 https://doi.org/10.1007/s42000-019-00140... . Also, GCs with theca cells are the main steroidogenic cells of the ovary. The development of follicles in the ovaries begins with the proliferation of GCs, which change their shape from flat to cubic and from a single layer to a multilayer, depending on the follicular phase3 3 Greenfield A. The molecular genetic basis of fetal granulosa cell development. Curr Opin Endocr Metab Res. 2021;18. –5 5 Dompe C, Kulus M, Stefańska K, Kranc W, Chermuła B, Bryl R, et al. Human granulosa cells-stemness properties, molecular cross-talk and follicular angiogenesis. Cells. 2021;10(6):1396. https://doi.org/10.3390/cells10061396 https://doi.org/10.3390/cells10061396... . The aim of the present document was to perform a narrative review, focusing on the role of GCs in follicle maturation and oocyte quality, as well as in the molecular mechanisms involved in this process.

25 February 2026 in Clinics
Verified
Journal Article
Open access
MAMayara Souza Alves
Mayara Souza Alves
LDLUCIANA LAMARAO DAMOUS
LUCIANA LAMARAO DAMOUS
IFIsaque da Silva Ferreira
Isaque da Silva Ferreira
CFCecília da Silva Ferreira
Cecília da Silva Ferreira
Isabel SorpresoIsabel Sorpreso
Isabel Sorpreso
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
Breast cancer remains a major health concern for women because of its prevalence and high morbidity and mortality rates. Metastasis represents the most severe prognosis, and many studies have been conducted to understand the mechanisms involved in cell migration and the factors influencing this process. To evaluate the effects of melatonin on breast cancer cells through a systematic literature review. Systematic review of the literature was carried out through PubMed, Embase and Web of Science as scientific search platforms using Population, Intervention, Comparison, and Outcome (PICO) with the keywords (P) "rat" or "murine"; (I) "melatonin'', "pineal'' and "indolamine''; (C) "breast cancer model'', "mammary cancer model'' and "breast tissue'' and (O) "proliferation" and "cell migration." The inclusion criteria were full-text, open-access articles in Portuguese, English, or Spanish that focused on the antioxidant and proapoptotic actions of melatonin on breast cancer cells. The exclusion criteria were articles published >20-years ago, those with missing methodological information, and those not describing the dosage and specificity of the research product used. The findings of each included study were structured in tables with details about the sample size, dose of melatonin, and route of administration. The quality of evidence was assessed using the Cochrane risk-of-bias tool. This study was registered in PROSPERO (n° CRD42025635531). A total of 257 articles were selected from the databases; 25 were read in full, resulting in 10 articles selected for this systematic review, with a total population of 756 animals studied. From the studies analyzed, six showed a reduction in tumors in correlation with the apoptosis process. This review shows that melatonin can inhibit tumorigenesis in three studies with the lowest risk of bias, which reinforces the oncostatic action of melatonin. However, several studies have combined other substances to evaluate their oncostatic action, making it difficult to infer the mechanisms involved. Further studies are necessary to elucidate the mechanisms through which melatonin acts in mammary carcinogenesis. The literature shows that in animal models of breast tumors, high doses of melatonin can induce tumor reduction by cell death through apoptosis. However, further studies are required to understand the mechanisms by which this hormone acts in mammary carcinogenesis.

1 January 2026 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
CACagri Akalin
Cagri Akalin
ISIlker Sengul
Ilker Sengul
DSDemet Sengul
Demet Sengul
HTHalil Ibrahim Tas
Halil Ibrahim Tas
GNGabriela Bezerra Nóbrega
Gabriela Bezerra Nóbrega
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
SUMMARY OBJECTIVE: The aim of this study was to evaluate affective temperament, emotion regulation, and anxiety–depression symptoms in women with idiopathic granulomatous mastitis, and to determine whether these psychological factors predict clinically relevant outcomes. METHODS: This case–control study included 97 patients with idiopathic granulomatous mastitis and 100 healthy controls. Affective temperament, emotion regulation, and anxiety–depression symptoms were assessed using the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire, the Difficulties in Emotion Regulation Scale, and the Hospital Anxiety and Depression Scale, respectively. Multivariable logistic regression analyses had been performed to identify psychological predictors of recurrence, treatment resistance, and fistula formation. RESULTS: Between-group analyses showed higher depressive and anxious temperament traits in women with idiopathic granulomatous mastitis, greater emotion regulation difficulties, and elevated anxiety–depression symptoms (all p<0.001). Emotion regulation impairment independently predicted treatment resistance (OR 2.86, p=0.004). In contrast, anxious temperament was inversely associated with both recurrence (OR 0.33, p=0.012) and treatment resistance (OR 0.35, p=0.010). No psychological variable predicted fistula formation. CONCLUSION: Idiopathic granulomatous mastitis is associated with a distinct psychosomatic vulnerability profile. While impaired emotion regulation increases the risk of refractory disease, anxious temperament may be linked to protective vigilance-related behaviors. These findings support the integration of psychoneuroimmunology-informed psychological assessment into idiopathic granulomatous mastitis management.

1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
CFCecília da Silva Ferreira
Cecília da Silva Ferreira
KCKatia Candido Carvalho
Katia Candido Carvalho
IFIsaque da Silva Ferreira
Isaque da Silva Ferreira
GCGiovanna Santos Cavalcanti
Giovanna Santos Cavalcanti
JNJosé Cipolla Neto
José Cipolla Neto
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
The influence of prolactin (PRL) and melatonin on breast cancer represents a complex interplay of hormonal signaling with significant implications for tumor progression and therapeutic strategies. PRL, a polypeptide hormone produced primarily by the pituitary gland but also locally in mammary tissue, plays a dual role in breast physiology and pathology1. It acts synergistically with estrogen and progesterone to promote proliferation and differentiation of mammary epithelial cells, processes that are essential for lactation1,2. However, its involvement in breast cancer remains debated, with most studies suggesting proliferative and pro-metastatic effects. PRL exerts its actions through specific transmembrane receptors (prolactin receptor [PRLR])1,2, activating signaling pathways such as JAK2/STAT5, Ras/MAPK, and PI3K/AKT, which drive cell survival, proliferation, and differentiation. Controversially, while PRL overexpression in cell culture enhances tumor growth, PRLR knockdown or antagonism can lead to more aggressive but less differentiated tumors, highlighting the context-dependent nature of PRL's role in breast cancer. Therefore, blood PRL concentration is important for the development of cancer1-4.